New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: BPZ Resources Inc (NYSE:BPZ), Triangle Petroleum Corporation (NYSEMKT:TPLM), Marina Biotech, Inc (OTCMKTS:MRNA), Precision Drilling Corp (USA) (NYSE:PDS)
BPZ Resources Inc (NYSE:BPZ) showed a volume of 1.43 million shares by the end of last trade whereas the average volume of the stock remained 744,599.00 shares. The stock opened the session at $2.07 but then moved to $2.14. At that price, the stock showed a positive performance of 5.94%. BPZ Resources, Inc. (BPZ) is focused on the exploration, development and production of oil and natural gas in Peru and Ecuador. The Company also intends to utilize part of its natural gas production as a supply source for the complementary development of a gas-fired power generation facility in Peru. It maintains a subsidiary, BPZ Exploracion & Produccion S.R.L. (BPZ E&P), through its wholly owned subsidiary BPZ Energy International Holdings, L.P. and its subsidiary BPZ Energy,
Will BPZ Continue To Move Higher? Find Out Here
Triangle Petroleum Corporation (NYSEMKT:TPLM) opened the session at $8.40 and closed the session at $8.24. The stock showed a positive performance of 0.12% in previous trading session. Traded with volume of 1.43 million shares in the prior session and the average volume of the stock remained 1.76 million shares. Triangle Petroleum Corporation (Triangle) is an exploration and production company ,which is focused on the development of unconventional shale oil and natural gas resources in the Bakken Shale and Three Forks formations in the Williston Basin of North Dakota and Montana. As of January 31, 2012, the Company owned approximately 83,000 net acres in McKenzie and Williams Counties of North Dakota and Roosevelt and Sheridan Counties of Montana.
For How Long TPLM will fight for Profitability? Read This Trend Analysis report
Marina Biotech, Inc (OTCMKTS:MRNA) opened the session at $0.47 and closed the session at $0.700. The stock showed a positive performance of 52.17% in previous trading session. Traded with volume of 1.42 million shares in the prior session and the average volume of the stock remained 138,400.00 shares. The beta of the stock remained 1.32. Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies utilizing gene silencing approaches such as RNA interference (RNAi) and blocking messenger RNA (mRNA) translation. The Company's pipeline includes a clinical program in Familial Adenomatous Polyposis (FAP) and preclinical programs in bladder cancer and myotonic dystrophy. The Company has two liposomal-based delivery platforms.
Why Should Investors Buy MRNA After The Recent Gain? Just Go Here and Find Out
Precision Drilling Corp (USA) (NYSE:PDS) the stock decreased -1.63% and finished the session at $9.03. Traded with volume of 1.41 million shares in the prior session and the average volume of the stock remained 1.50 million shares. The beta of the stock remained 2.71. Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas exploration and production companies in Canada and the United States. The Company operates in two segments: Contract Drilling Services, and Completion and Production Services. In Canada, the Contract Drilling Services segment includes land drilling services, directional drilling services,
Will PDS Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)